These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21049734)

  • 21. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
    Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
    Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.
    Kakita LS; Lowe NJ
    Clin Ther; 1998; 20(5):960-70. PubMed ID: 9829447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
    Torok H; Taylor S; Baumann L; Jones T; Wieder J; Lowe N; Jarret M; Rich P; Pariser D; Tschen E; Martin D; Menter A; Weiss J
    J Drugs Dermatol; 2005; 4(5):592-7. PubMed ID: 16167418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Evaluation of Efficacy and Tolerability of Novel Enzyme Exfoliation Versus Glycolic Acid in Photodamage Treatment.
    Mekas M; Chwalek J; MacGregor J; Chapas A
    J Drugs Dermatol; 2015 Nov; 14(11):1306-19. PubMed ID: 26580881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin lightening preparations and the hydroquinone controversy.
    Draelos ZD
    Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin versus 20% glycolic acid/10% L-ascorbic acid).
    Ash K; Lord J; Zukowski M; McDaniel DH
    Dermatol Surg; 1998 Aug; 24(8):849-56. PubMed ID: 9723049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
    Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
    J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma.
    Costa A; Moisés TA; Cordero T; Alves CR; Marmirori J
    An Bras Dermatol; 2010; 85(5):613-20. PubMed ID: 21152784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hydroquinone formulation with increased stability and decreased potential for irritation.
    Smiles KA; Dong KK; Canning MT; Grimson R; Walfield AM; Yarosh DB
    J Cosmet Dermatol; 2007 Jun; 6(2):83-8. PubMed ID: 17524123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial.
    Poli F; Ribet V; Lauze C; Adhoute H; Morinet P
    Dermatology; 2005; 210 Suppl 1():14-21. PubMed ID: 15724103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
    Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
    J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing.
    West TB; Alster TS
    Dermatol Surg; 1999 Jan; 25(1):15-7. PubMed ID: 9935086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different therapeutic modalities for treatment of melasma.
    Azzam OA; Leheta TM; Nagui NA; Shaarawy E; Hay RM; Hilal RF
    J Cosmet Dermatol; 2009 Dec; 8(4):275-81. PubMed ID: 19958431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.